Entera Bio Ltd (ENTX) has released an update to notify the public and investors about a regulation fd disclosure.
On December 22, 2023, Entera Bio Ltd. completed a private placement of securities with certain accredited investors and agreed to a registration rights agreement mandating the registration of the securities for resale. In compliance with this agreement, Entera Bio filed a registration statement with the SEC on February 2, 2024, to register these securities.
For further insights into ENTX stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
